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Objectives This study sought to investigate the association between pathological characteristics of
aspirated intracoronary thrombi and the incidence of angiographically visible distal embolization
(AVDE) during primary percutaneous coronary intervention (p-PCI) in patients with ST-segment ele-
vation myocardial infarction (STEMI) treated with thrombus aspiration.
Background AVDE of atherosclerotic and thrombotic material has been shown to impair myocardial
perfusion and contribute to poor clinical outcome in patients with STEMI. Recent studies have
shown that thrombus composition and size are associated with the incidence of AVDE.
Methods Aspirated thrombi from 164 STEMI patients within 12 h of symptom onset were investi-
gated immunohistochemically using antibodies against platelets, erythrocytes, and inﬂammatory
cells.
Results The angiographic results showed that AVDE during p-PCI occurred in 22 (13.4%) patients.
Pathological analysis revealed that thrombi from patients with AVDE had a greater erythrocyte-posi-
tive area (60  15% vs. 43  21%, p  0.0005) and more myeloperoxidase-positive cells (943  324
cells/mm2 vs. 592  419 cells/mm2, p  0.0005) than those from patients without AVDE. Thrombus
size, quantiﬁed as the thrombus surface area, was positively correlated with the erythrocyte compo-
nent (r  0.362, p  0.0001). Moreover, multivariate logistic analysis demonstrated that erythrocyte-
positive area in the thrombi, glucose levels on admission, larger vessel diameter (3.5 mm), and
pre-balloon dilation were independent predictors of the incidence of AVDE.
Conclusions This study demonstrated that the erythrocyte-rich component of aspirated thrombi
may be associated with the incidence of AVDE during p-PCI in patients with STEMI. (J Am Coll
Cardiol Intv 2013;6:377–85) © 2013 by the American College of Cardiology Foundation
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378Primary percutaneous coronary intervention (p-PCI) has
significantly improved myocardial perfusion and survival
after acute ST-segment elevation myocardial infarction
(STEMI). However, despite the recent technical and me-
chanical improvements in percutaneous coronary interven-
tion (PCI), a substantial number of STEMI patients treated
with PCI show inadequate perfusion of the infarcted myo-
cardium (1,2). During PCI, embolization of atherosclerotic
and thrombotic material often occurs and can be visible on
the coronary angiogram as a distal filling defect with abrupt
cutoff in the distal vessel of the culprit lesion. This angio-
graphically visible distal embolization (AVDE) of thrombus
and plaque debris was found in 6% to 18% of patients with
STEMI treated with PCI and was one of the major complica-
tions that could be closely associated with impairment of myocar-
dial perfusion and poor clinical outcome (1–4).
Previous studies have demon-
strated that plaque volume and
composition, especially necrotic
core volume, is associated with
AVDE in patients with STEMI
(5). Moreover, the presence of
an intracoronary thrombus at
the lesion site has been shown to
provide an increased risk of dis-
tal embolization (3,4). In fact,
recent studies using thrombec-
tomy or distal protection devices
have demonstrated that the use
of these devices significantly re-
duced the incidence of distal em-
bolization and improved myocardial
perfusion (2,6,7) and clinical out-
come (8). A coronary thrombus
consists mainly of platelets, eryth-
rocytes, and fibrin, and often con-
tains inflammatory cells. A recent
study showed that thrombus com-
osition and size were associated with AVDE after PCI, and
he thrombi aspirated in patients with distal embolization were
arger and contained more erythrocytes than thrombi aspirated
n patients without distal embolization (4). Moreover, our
ecent study demonstrated that erythrocyte-rich thrombi were
ssociated with poor myocardial perfusion, as assessed by
T-segment resolution and myocardial blush grade, after PCI
n patients with STEMI (9). However, few data are available in
etail on pathological characteristics of aspirated intracoronary
hrombi in STEMI patients with and without AVDE.
Accordingly, the aim of the present study was to determine
he association between pathological characteristics of aspirated
ntracoronary thrombi and the incidence of AVDE in patients
ith STEMI treated with thrombus aspiration. This study was
substudy of our previous report using aspirated intracoronary
Abbreviations
and Acronyms
AVDE  angiographically
visible distal embolization
CPK  creatine
phosphokinase
DM  diabetes mellitus
GP  glycoprotein
IRA  infarct-related artery
MPO  myeloperoxidase
PCI  percutaneous
coronary intervention
p-PCI  primary
percutaneous coronary
intervention
STEMI  ST-segment
elevation myocardial
infarction
TIMI  Thrombolysis In
Myocardial Infarctionhrombi in STEMI patients (9). methods
Study patients. Between January 2004 and December 2008,
310 STEMI patients were admitted to our hospital, and of
those, the study included 249 consecutive STEMI patients
within 12 h of symptom onset who had undergone throm-
bus aspiration for de novo lesions. Sixty-one patients were
excluded because 55 patients had symptoms for 12 h
and/or had not had thrombus aspiration performed during
PCI, and 6 patients developed stent restenosis/thrombosis.
The AngioJet Thrombectomy catheter (Medrad, Warren-
dale, Pennsylvania) was not used nor were other thrombus
disruption techniques performed during PCI. The inclusion
and exclusion criteria were almost the same as our previous
report (9), but we additionally excluded patients in whom a
distal protection device was used during PCI in this study
(n  15). Other reasons for exclusion are as follows: 50%
left main coronary artery stenosis (n  6), thrombolytic
therapy before PCI (n  6), previous coronary bypass
surgery (n  2), renal dysfunction (serum creatinine levels
2.0 mg/dl; n 10), concomitant inflammatory diseases or
malignant tumors (n  5), no material obtained by aspira-
tion (n  32), and not immunohistochemically classifiable
due to a small tissue sample size (n  9). Ultimately, 164
patients (126 men, mean age, 65  12 years) were enrolled
in the study. Ninety-six of the 164 patients were already
reported in our previous study (9). All patients were taking
aspirin and received 200 mg of ticlopidine or a 300-mg
loading dose of clopidogrel before the procedure. Glycopro-
tein (GP) IIb/IIIa inhibitors were not used, because they
had not been approved in Japan.
All the studies were approved by the ethics committee of
Osaka City General Hospital, and written informed consent
was obtained from all patients before the procedure.
Interventional procedure and angiographic outcomes. The
nfarct-related artery (IRA) was defined as a major coronary
rtery perfusing an area compatible with the distribution of
T-segment elevation in the 12-lead electrocardiogram.
he patency of the IRA was assessed by angiography before
CI according to the Thrombolysis In Myocardial Infarc-
ion (TIMI) flow grade. Intracoronary thrombus at baseline
as identified by angiography and assigned 1 of 5 scores
ccording to the TIMI thrombus score (9). Subsequent PCI
as performed for total occlusive lesions or lesions with
75% diameter stenosis, even with TIMI flow grade 3. All
CI procedures were performed using a femoral approach
ith a 7-F guiding catheter. After administration of 5,000
U of heparin and conventional wire crossing, thrombus
spiration was performed using a single thrombectomy
evice (7-F Thrombuster catheter, Kaneka, Tokyo, Japan)
hrough the target coronary segment 2 times until
hrombi were angiographically invisible as determined by
he operator’s judgment. Intracoronary nitroglycerin (0.25
g) was administered just before angiography both before
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379and after thrombus aspiration. Angiography was performed
with each lesion viewed from 2 angles. Off-line quantita-
ive coronary angiography was conducted using the view
howing the greatest degree of stenosis. Left ventriculogra-
hy was performed on admission, and the left ventricular
jection fraction was calculated. Angiographic analysis was
erformed by 2 independent cardiologists who were un-
ware of the patients’ characteristics and histological classi-
cations of aspirated intracoronary thrombi. In cases of
isagreement, consensus was reached by further joint
eading.
Deﬁnition of AVDE. AVDE was defined as a distal filling
defect with abrupt cutoff in the distal vessel of the culprit
lesion at any stage during PCI under conditions of all usable
agents (dual antiplatelet agents and heparin infusion) with-
out evidence of dissection, stenosis, or vasospasm. The
evaluation of AVDE was conducted based on the coronary
angiogram during the PCI procedure. The occurrence of
no-reflow (TIMI flow grade 0 or 1) during PCI even with
TIMI flow grade 2 or 3 by the initial angiogram was also
classified as AVDE, but the occurrence of TIMI flow
impairment without evidence of a distal filling defect at any
stage of the procedure was not classified as AVDE.
Biochemical analysis. Venous blood samples from all pa-
tients were obtained from the forearm using standard
venipuncture on admission to the hospital, before heparin
administration. The concentration of high-sensitivity
C-reactive protein was measured using the latex agglutina-
tion photometric immunoassay with an automated immu-
nochemistry analyzer (LXz-6000, Eiken Chemical, Tokyo,
Japan) with normal values 0.3 mg/dl.
Analysis of aspirated samples. The retrieval of the thrombus
as done via aspiration through the catheter lumen, and
ollected from the device filter. Collected thrombi were
mmediately washed with saline, snap-frozen, and then
tored at 80°C. Frozen samples of aspirated thrombi were
erially sectioned to produce 5-m-thick sections and then
xed in acetone. Each first and second section was stained
ith hematoxylin-eosin, and the cellular components were
nalyzed using monoclonal antibodies against a protein
pecific to erythrocyte membranes (glycophorin-A, Dako,
lostrup, Denmark), platelet GP IIb/IIIa (CD41, Dako),
ctivated platelets (P-selectin [CD62P, Dako]), smooth
uscle cell actin (1A4, Dako), macrophages (HAM56,
ako), neutrophils (CD66b [80H3, Beckman Coulter,
ullerton, California]), and myeloperoxidase (MPO)
MPO-7, Dako). Sections were incubated at 4°C overnight
r for 1 h at room temperature and then subjected to a
-step staining procedure using the streptavidin-biotin
omplex method for detection. Peroxidase activity was
isualized with 3-amino-9-ethyl-carbazole (Sigma-Aldrich
o. LLC, St. Louis, Missouri) (10 min, room temperature),
nd the sections were faintly counterstained with hematox-
lin. The tissue areas that were stained positive for eryth-ocytes (glycophorin-A) and P-selectin–positive platelets
ere quantified using computer-aided planimetry and ex-
ressed as a percentage of the total thrombus surface area.
he numbers of MPO-positive cells were counted in all the
issue sections, and expressed as the number of cells per
m2 of tissue. Morphometric analysis was performed by a
ingle investigator who was blinded to the patient and
ngiographic characteristics.
Statistical analysis. The results for normally distributed
continuous variables are expressed as mean  SD, and
continuous variables that did not follow a normal distribu-
tion are presented as median (interquartile range). The
Mann–Whitney U test was used to compare the groups of
patients with and without AVDE. Categorical variables
were compared using a chi-square test or Fisher exact test.
Pearson correlation coefficients were calculated to assess the
relationships between thrombus size, quantified as the
thrombus surface area, and the erythrocyte- or platelet-
positive areas and the number of MPO-positive cells.
Univariate and multivariate logistic regression analysis was
performed to identify the independent factors associated
with the incidence of AVDE. Univariate analysis included
baseline patient characteristics, previously reported factors
associated with AVDE, and other conceivable parameters,
and multivariate analysis included significant (p  0.05)
factors in univariate analysis. All analyses used 2-sided tests
with a significance level of p  0.05. Data were analyzed
using SPSS version 16.0 for Windows (SPSS, Chicago,
Illinois).
Results
Clinical presentation, biochemical analysis, and angiographic
ﬁndings. The angiographic results showed that AVDE
during p-PCI occurred in 22 (13.4%) patients. The baseline
characteristics and biochemical analysis in patients with and
without AVDE are shown in Table 1. In patients with
AVDE, diabetes mellitus (DM) tended to be more preva-
lent (p  0.06), and on-admission glucose levels were
significantly higher (p  0.035) than in patients without
AVDE. Moreover, serum maximum creatine phosphoki-
nase (CPK) and CPK-myocardial band (CPK-MB) levels
were significantly higher in patients with than without
AVDE (CPK, p  0.04; CPK-MB, p  0.01).
Angiographic findings and acute procedural results are
presented in Table 2. The baseline angiogram revealed a
higher rate of occlusion in the IRA (p  0.08) and higher
(flow grade 3) TIMI thrombus score (p  0.08) in
patients with AVDE, but the differences did not reach
significance. Furthermore, there was a larger vessel diameter
(p  0.02) and a longer stent length (p  0.01) in patients
with AVDE, and more patients with AVDE used pre-
balloon dilation (p  0.01) and required the use of an
p
c
p
f
(
i
w
w
p
e
g
w
m
e
w
r
A
m
0
s
p
n

a
J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S , V O L . 6 , N O . 4 , 2 0 1 3
A P R I L 2 0 1 3 : 3 7 7 – 8 5
Yunoki et al.
Thrombus Characteristics and Distal Embolization
380intra-aortic balloon pump for cardiogenic shock or no-
reflow (p  0.005).
Histological ﬁndings in aspirated samples. In aspirated sam-
les, histopathological analysis revealed only thrombus
omponents in 118 patients (72%), and both thrombus and
laque fragments, which contained macrophage-derived
oam cells and occasional smooth muscle cells, in 46 patients
28%). Representative micrographs of an aspirated thrombi
n a patient with AVDE are shown in Figure 1. In patients
ith AVDE, the glycophorin-A–positive erythrocytes area
as usually large (Figs. 1A and 1B), whereas the P-selectin–
ositive platelets area, which was the inverse of the
rythrocyte-positive area, was usually small (Fig. 1C). Re-
arding inflammatory cells, the thrombi were infiltrated
ith abundant MPO-positive cells (Fig. 1D). Results of the
orphometric analysis are shown in Figure 2. The
Table 1. Baseline Clinical Characteristics Between P
AVDE () (
Age, yrs 63.5
Men 21 (95)
Body mass index, kg/m2 23.7
Hypertension 13 (59)
Diabetes mellitus 12 (55)
Smoking 17 (77)
Total cholesterol, mg/dl 195
HDL cholesterol, mg/dl 46
LDL cholesterol, mg/dl 129
Triglycerides, mg/dl 114
Glucose, mg/dl 221
HbA1c, % 6.6
OMI 3 (14)
Previous AP 4 (18)
Elevated TnT 0.1 ng/ml 13 (59)
Max CPK, U/l 6,052
Max CPK-MB, U/l 670
Killip class 2 5 (23)
Reperfusion time, min 349
Medications at hospital admission
Aspirin 8 (36)
ACE inhibitors/ARB 5 (23)
Beta-blockers 1 (5)
Calcium antagonists 9 (41)
Nitrates 2 (9)
Statins 2 (9)
Leukocyte count, mm3 10,896
Neutrophil count, mm3 8,417
Hs-CRP, mg/dl 0.33 (0.13
Values are mean SD, n (%), or median (interquartile range).
 positive; negative; ACE angiotensin-converting enzyme
angiographically visible distal embolization; CPK  creatine phosp
glycosylated hemoglobin; HDL high-density lipoprotein; Hs-CRP
myocardial infarction; TnT troponin T.rythrocyte-positive area was significantly greater in patients pith than without AVDE (60  15% vs. 43  21%,
espectively, p  0.0005). By contrast, the percentage of
P-selectin–positive platelets was significantly less in patients
with than without AVDE (26  17% vs. 46  21%,
respectively, p  0.0001). Furthermore, patients with
VDE had more MPO-positive cells (943  324 cells/
m2 vs. 592  419 cells/mm2, p  0.0005).
With regard to thrombus size, the thrombus surface area
was significantly greater in patients with than without
AVDE (7.20  6.94 mm2 vs. 3.32  4.97 mm2, p 
.0005) (Fig. 3A). As shown in Figures 3B to 3D, thrombus
urface area was positively associated with the erythrocyte-
ositive area (r  0.362, p  0.0001) (Fig. 3B) and
egatively associated with the platelet-positive area (r 
0.239, p  0.005) (Fig. 3C). Moreover, thrombus surface
rea was positively associated with the number of MPO-
ts With and Without AVDE
2) AVDE () (n  142) p Value
65.0 11.9 0.37
105 (74) 0.11
24.2 3.3 0.60
84 (59) 0.96
43 (30) 0.06
80 (56) 0.11
202 51 0.81
51 13 0.13
131 44 0.54
103 64 0.40
182 68 0.035
6.3 1.6 0.32
18 (13) 0.98
50 (35) 0.20
71 (50) 0.46
3,429 2,993 0.04
338 285 0.01
30 (21) 0.90
309 179 0.52
31 (22) 0.27
34 (24) 0.93
13 (9) 0.73
50 (35) 0.63
12 (8) 0.96
17 (12) 0.83
10,707 3,811 0.81
7,900 3,689 0.63
0.24 (0.08–0.44) 0.08
ngina pectoris; ARB angiotensin II type 1 receptor blocker; AVDE
se; CPK-MB  creatine phosphokinase myocardial band; HbA1c 
nsitivity C-reactive protein; LDL low-density lipoprotein; OMI oldatien
n  2
9.6
3.5
47
14
44
64
134
1.3
6,106
635
224
3,722
3,964
–0.89)
; AP a
hokina
high-seositive cells (r  0.443, p  0.0001) (Fig. 3D).
J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S , V O L . 6 , N O . 4 , 2 0 1 3 Yunoki et al.
A P R I L 2 0 1 3 : 3 7 7 – 8 5 Thrombus Characteristics and Distal Embolization
381Erythrocyte component of thrombi and AVDE. The results of
univariate and multivariate analyses of factors associated
with AVDE are listed in Table 3. Multivariate analysis
revealed that the independent factors associated with the
incidence of AVDE were on-admission glucose levels (ad-
justed odds ratio [95% confidence interval]: 1.008 [1.001 to
1.014]; p 0.0258), larger vessel diameter (3.964 [1.238 to
12.692]; p  0.0203), pre-balloon dilation (7.561 [1.944
to 29.408]; p  0.0035), and erythrocyte-positive area
(1.055 [1.020 to 1.091]; p  0.0018).
Discussion
In several previous studies, histopathological analysis was
performed to determine the components of intracoronary
thrombi aspirated from STEMI patients (10–12). How-
ever, these studies were based on thrombus materials fixed
in formalin, and they did not evaluate platelets and eryth-
rocytes using immunohistochemical methods with specific
antibodies. Our study used frozen thrombus samples, be-
cause monoclonal antibodies against P-selectin and GP
IIb/IIIa work well only on frozen sections. To the best of our
knowledge, the present study is the first to pathologically
Table 2. Baseline Angiographic Data and Procedural
AVDE () (n 
Infarct-related artery
LAD/RCA/LCX 8/13/1 (36/59
Initial TIMI ﬂow grade
0/1–2/3 19/2/1 (86/9/
Multivessel disease 7 (32)
Rentrop collateral grading 2 4 (18)
TIMI thrombus score 3 21 (95)
Pre-balloon dilation 18 (82)
Post-stent dilation 4 (18)
IABP use 9 (41)
Stent implantation 20 (91)
Stents per lesion 1.22 1.1
Stent size, mm 3.62 0.3
Stent length, mm 29.5 26.
QCA analysis, baseline
Reference diameter, mm 3.68 0.7
MLD, mm 0.10 0.2
% DS 97.2 5.6
QCA analysis (after PCI)
MLD, mm 3.07 0.9
Acute gain, mm 2.96 0.9
%DS 15.9 23.
Ejection fraction, % 44.3 12.
Values are n (%), n/n/n (N/N/N), or mean SD.
DS diameter stenosis; IABP intra-aortic balloon pump; LAD l
minimal lumen diameter; QCA  quantitative coronary angiography
other abbreviations as in Table 1.demonstrate that the erythrocyte-rich component in aspiratedcoronary thrombi is closely associated with thrombus size and
the incidence of AVDE during p-PCI in STEMI patients.
Previous studies evaluated factors that increase the risk of
distal embolization. Treatment of right coronary artery or
vein grafts, low TIMI flow grade before PCI, higher TIMI
thrombus score, longer target lesion, and larger vessel
diameter have all been shown to be associated with the risk
of distal embolization (3,4,13). These findings suggest that
distal embolization occurs more frequently during PCI in
lesions with high thrombus or high plaque burden. How-
ever, previous studies did not fully evaluate the association
between histopathological characteristics of intracoronary
thrombus components and distal embolization. Our study
clearly demonstrates that the erythrocyte component is
significantly associated with a high thrombus burden that
increases the risk of distal embolization. These results may
reflect the mechanism of thrombosis whereby an initial
platelet-rich thrombus, aggregated and formed at the site of
plaque disruption or erosion, grows with an increase in the fibrin
component, trapping large numbers of erythrocytes and inflam-
matory cells to form an erythrocyte-rich thrombus (14–18).
The important finding of the present study is that
ts Between Patients With and Without AVDE
AVDE () (n  142) p Value
0.91
61/68/13 (43/48/9)
0.08
89/33/20 (63/23/14)
43 (30) 0.87
20 (14) 0.76
104 (73) 0.08
75 (53) 0.01
40 (28) 0.33
1 (1) 0.005
136 (96) 0.72
1.09 0.43 0.97
3.40 0.40 0.07
20.3 8.2 0.01
3.29 0.51 0.02
0.11 0.23 0.91
96.5 7.0 0.57
2.87 0.52 0.03
2.76 0.59 0.06
12.4 13.4 0.92
47.8 10.4 0.19
rior descending coronary artery; LCX left circumflex artery; MLD
right coronary artery; TIMI  Thrombolysis In Myocardial Infarction;Resul
22)
/5)
5)
7
4
3
2
1
3
2
7
1
eft ante
; RCA inflammatory cells, such as MPO-positive cells, in the
m; (B
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382thrombi specimens were greater in patients with than
without AVDE. Moreover, the number of MPO-positive
cells in the thrombus specimens was significantly associated
Figure 1. Representative Micrographs of an Aspirated Thrombus From a Pa
(A) Immunostaining for erythrocytes (glycophorin-A). The boxed area is enlarged in B
lets (P-selectin). (D) Immunostaining for myeloperoxidase (MPO-7). Scale bar: (A) 500 
Figure 2. Morphometric Analysis of Aspirated Thrombi in Patients With and
Graphs showing glycophorin-A– and P-selectin–positive areas expressed as pe
(MPO)-positive cells expressed per mm2 of tissue in patients with and without
tive;   negative; other abbreviations as in Figure 1.with thrombus size. Previously, we reported that the vast
majority of MPO-positive cells were neutrophils, whereas
only occasional MPO-positive cells were macrophages,
With AVDE
(B) Immunostaining for erythrocytes (glycophorin-A). (C) Immunostaining for plate-
to D) 100 m. AVDE  angiographicly visible distal embolization.
out AVDE
ges of the total thrombus surface area and the number of myeloperoxidase
. Solid bars  AVDE () group; shaded bars  AVDE () group.   posi-tient
to D.With
rcenta
AVDE
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383based on double-immunostaining techniques (19). Our
study and others have also shown that high neutrophil
aggregates that stain positive for MPO and CD66b in an
aspirated thrombus are associated with impaired coronary
microcirculation, as assessed by ST-segment resolution and
myocardial blush grade, in patients with STEMI (9,12).
MPO is a strong pro-oxidant heme protein released mainly
from activated neutrophils in vascular lesions. It has been
reported that activated neutrophils can induce alterations of
erythrocyte properties, which result in hyperaggregability
(20), and increase the expression of tissue factor activity,
leading to a thrombotic state (21). Hence, our present
observations and these previous data suggest that activated
neutrophils present at the site of disrupted plaques or
thrombi may affect thrombus composition and growth,
which could lead to poor procedural outcome during PCI in
patients with STEMI.
In our study, multivariate analysis revealed that plasma
glucose levels on admission were an independent factor
associated with AVDE. The underlying mechanism respon-
sible for the adverse effects of hyperglycemia may have
several explanations. Hyperglycemia has been shown to
increase the expression of proinflammatory cytokines, re-
Figure 3. Relationships Between Thrombus Size and Components
(A) Graph showing total thrombus surface area (thrombus size) in patients wit
group. (B to D) Correlations between thrombus surface area and the erythroc
cells (D). Abbreviations as in Figures 1 and 2.sulting in plugging of leukocytes in the capillaries that mayimpair myocardial perfusion (22,23). Moreover, hypergly-
cemia may also augment thrombus formation (24), and
erythrocyte aggregation is reported to be increased in DM
patients (25). In fact, previous studies have demonstrated a
positive relationship between acute hyperglycemia and no-
reflow in patients with STEMI (26,27). Additionally, DM
has been shown to be associated with impaired myocardial
perfusion after primary angioplasty in patients with STEMI
(28). These findings are of considerable interest, because
they suggest that plasma glucose concentration may influ-
ence blood properties and contribute to the evolution of
thrombus formation and growth.
On the basis of our study, an erythrocyte-rich component
often reflects high thrombus burden, which increases the
risk of AVDE. Therefore, the evaluation of thrombus
burden or color using, not only coronary angiography, but
also intravascular imaging modalities, such as ultrasound,
angioscopy, or optical coherence tomography, may provide
important information about the amount of thrombus that
should be aspirated or if distal protection devices should be
used during PCI.
Study limitations. First, this study was a nonrandomized,
without AVDE. Solid bar  AVDE () group; shaded bar  AVDE ()
sitive areas (B), platelet-positive areas (C), and the number of MPO-positiveh and
yte-porelatively small study, and included only patients who had
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384thrombus aspiration performed during p-PCI. In addition,
our study excluded patients with no thrombus material or
very small, unanalyzable material obtained by aspiration.
Therefore, a degree of patient selection bias may have
occurred. Second, we could not perform a contemporary
assessment of plaque morphology or volume. Because
plaque volume and composition have been shown to be
associated with distal embolization, further studies using
ultrasound or optical coherence tomography are needed to
assess the relationship between thrombus characteristics and
plaque morphology. Third, we were unable to assess
whether retrieval of the thrombus was complete or whether
the thrombus we analyzed was head or tail, surface or center.
Because measurement of the actual amount of thrombus
present in the vessel was difficult in the use of coronary
angiography, and potential distortion of the samples might
have occurred by aspiration through the catheter lumen,
there is a possibility that the thrombus was misclassified if
only part of the thrombus was aspirated. Therefore, a
sampling bias must be considered in studies based on the
examination of these specimens. Finally, the antithrombotic
regimen used in this study was relatively dated because GP
IIb/IIIa inhibitors and other novel thrombolytic therapies
have not been approved for patients with STEMI in Japan.
Thus, dual antiplatelet therapy and heparin use were com-
Table 3. Univariate and Multivariate Logistic Analysi
Variables Univariate
Age, yrs 0.989 (0.950–1.029)
Men 7.400 (0.961–56.966
Hypertension 1.027 (0.412–2.559)
Hypercholesterolemia 0.457 (0.169–1.236)
Diabetes mellitus 2.857 (1.146–7.122)
Glucose levels on admission 1.005 (1.000–1.010)
Elevated TnT 0.1 ng/ml 1.527 (0.580–4.018)
Pre-infarction angina 0.409 (0.131–1.275)
Inferior myocardial infarction 1.572 (0.632–3.911)
OMI 1.022 (0.276–3.789)
Killip class 2 1.098 (0.375–3.219)
Time to reperfusion 6 h 2.258 (0.891–5.723)
Multivessel coronary disease 1.111 (0.423–2.922)
Rentrop collateral grading 2 0.739 (0.203–2.690)
Baseline TIMI ﬂow grade 0 3.772 (1.065–13.354
TIMI thrombus score 3 7.951 (1.034–61.142
Lesion length 20 mm 1.445 (0.576–3.625)
Vessel diameter 3.5 mm 3.390 (1.300–8.841)
Pre-balloon dilation 4.020 (1.295–12.476
Ejection fraction 35% 2.145 (0.701–6.566)
Percentage of erythrocyte area 1.043 (1.018–1.070)
Values are odds ratios (95% confidence intervals).
Abbreviations as in Tables 1 and 2.mon treatments for STEMI. However, recent studiesusing GP IIb/IIIa inhibitors for STEMI demonstrated
that early treatment with GP IIb/IIIa inhibitors resulted
in improvement of pre- and post-procedural TIMI flow
grades and less distal embolization during p-PCI (29).
Therefore, more aggressive antithrombotic treatment
might have an impact on thrombus characteristics and
procedural outcome.
Conclusions
The present study demonstrated that an erythrocyte-rich
component in aspirated coronary thrombi and plasma glu-
cose levels on admission were closely associated with the
incidence of AVDE during p-PCI in patients with STEMI
treated with thrombus aspiration. These findings suggest
that interaction among thrombus size, thrombus compo-
nents, and some factors influencing blood properties and/or
inflammation could be associated with procedural outcome
during PCI in patients with STEMI.
Reprint requests and correspondence: Dr. Makiko Ueda, De-
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redicting the Incidence of AVDE
p Value Multivariate p Value
0.59
0.0546
0.95
0.12
0.0243 2.329 (0.750–7.232) 0.14
0.0445 1.008 (1.001–1.014) 0.0258
0.39
0.12
0.33
0.97
0.86
0.09
0.83
0.65
0.0396 1.519 (0.299–7.728) 0.61
0.0463 4.193 (0.337–52.193) 0.27
0.43
0.0126 3.964 (1.238–12.692) 0.0203
0.016 7.561 (1.944–29.408) 0.0035
0.18
0.0009 1.055 (1.020–1.091) 0.0018s for P
)
)
)
)
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